Annual Working Capital
$9.13 M
-$37.68 M-80.50%
December 31, 2023
Summary
- As of February 7, 2025, VINC annual working capital is $9.13 million, with the most recent change of -$37.68 million (-80.50%) on December 31, 2023.
- During the last 3 years, VINC annual working capital has fallen by -$16.17 million (-63.92%).
- VINC annual working capital is now -90.68% below its all-time high of $97.92 million, reached on December 31, 2021.
Performance
VINC Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$6.32 M
-$6.63 M-51.17%
September 30, 2024
Summary
- As of February 7, 2025, VINC quarterly working capital is $6.32 million, with the most recent change of -$6.63 million (-51.17%) on September 30, 2024.
- Over the past year, VINC quarterly working capital has dropped by -$2.80 million (-30.72%).
- VINC quarterly working capital is now -93.55% below its all-time high of $98.09 million, reached on September 30, 2021.
Performance
VINC Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
VINC Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -80.5% | -30.7% |
| 3 y3 years | -63.9% | -92.7% |
| 5 y5 years | +10000.0% | +110.8% |
VINC Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -90.7% | at low | -93.5% | +313.9% |
| 5 y | 5-year | -90.7% | >+9999.0% | -93.5% | +110.2% |
| alltime | all time | -90.7% | >+9999.0% | -93.5% | +110.2% |
Vincerx Pharma Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $6.32 M(-51.2%) |
| Jun 2024 | - | $12.95 M(-538.0%) |
| Mar 2024 | - | -$2.96 M(-132.4%) |
| Dec 2023 | $9.13 M(-80.5%) | $9.13 M(-34.7%) |
| Sep 2023 | - | $13.97 M(-38.3%) |
| Jun 2023 | - | $22.66 M(-32.0%) |
| Mar 2023 | - | $33.30 M(-28.9%) |
| Dec 2022 | $46.81 M | $46.81 M(-18.3%) |
| Sep 2022 | - | $57.30 M(-20.3%) |
| Jun 2022 | - | $71.94 M(-16.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $86.54 M(-11.6%) |
| Dec 2021 | $97.92 M(+287.1%) | $97.92 M(-0.2%) |
| Sep 2021 | - | $98.09 M(+38.5%) |
| Jun 2021 | - | $70.82 M(+180.6%) |
| Mar 2021 | - | $25.24 M(-0.2%) |
| Dec 2020 | $25.30 M(<-9900.0%) | $25.30 M(-68.0%) |
| Sep 2020 | - | $79.02 M(-227.2%) |
| Jun 2020 | - | -$62.13 M(+5.9%) |
| Dec 2019 | -$44.00 K | - |
| Dec 2019 | - | -$58.67 M |
FAQ
- What is Vincerx Pharma annual working capital?
- What is the all time high annual working capital for Vincerx Pharma?
- What is Vincerx Pharma annual working capital year-on-year change?
- What is Vincerx Pharma quarterly working capital?
- What is the all time high quarterly working capital for Vincerx Pharma?
- What is Vincerx Pharma quarterly working capital year-on-year change?
What is Vincerx Pharma annual working capital?
The current annual working capital of VINC is $9.13 M
What is the all time high annual working capital for Vincerx Pharma?
Vincerx Pharma all-time high annual working capital is $97.92 M
What is Vincerx Pharma annual working capital year-on-year change?
Over the past year, VINC annual working capital has changed by -$37.68 M (-80.50%)
What is Vincerx Pharma quarterly working capital?
The current quarterly working capital of VINC is $6.32 M
What is the all time high quarterly working capital for Vincerx Pharma?
Vincerx Pharma all-time high quarterly working capital is $98.09 M
What is Vincerx Pharma quarterly working capital year-on-year change?
Over the past year, VINC quarterly working capital has changed by -$2.80 M (-30.72%)